Brief: Dabur Receives US FDA Warning Letter For Silvassa Plant
06/08/2026 14:17
BRIEF-Dabur Receives US FDA Warning Letter For Silvassa Plant Aug 6 (Reuters) - Dabur India Limited DABU.NS:
RECEIVES US FDA WARNING LETTER FOR SILVASSA PLANT
US FDA SEEKS ADDITIONAL DETAILS ON CORRECTIVE ACTION PLAN FROM DABUR INDIA
WARNING LETTER CONCERNS ONLY EXPORTS FROM SILVASSA PLANT; DOMESTIC PRODUCTS NOT IMPACTED
Source text: ID:nBSE1NlQg
Further company coverage: DABU.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dabur India
See all newsBrief: Dabur Says India Markets Regulator SEBI Has Issued An Administrative Warning Letter To Co
Dabur India falls on lower-than-expected quarterly margin, long-term CEO resignation
Dabur's global CEO resigns, India boss joins board (updated)
Brief: Dabur Says Mohit Malhotra Resigns As Global CEO And Whole-Time Director Effective November 13, 2026
Dabur India's global CEO Mohit Malhotra resigns